Selexis Inks Cell-Line License Agreement with ImmuNext
By

By
Selexis, a Geneva, Switzerland-based life sciences company, has signed a commercial license agreement that provides ImmuNext, a Lebanon, New Hampshire-based immunotherapy company, with access to research cell banks from the…

Nitto Denko Avecia Makes Acquisitions to Support Oligonucleotide Production
By

By
Nitto Denko Avecia, a Milford, Massachusetts-based provider of nucleic acid manufacturing and development services, has agreed to acquire the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals, both located in…

Merck KGaA Donates Worm-Disease Drug to WHO
By

By
Merck KGaA has donated its 500 millionth tablet of praziquantel to the World Health Organization to treat the worm disease, schistosomiasis. The medicine will be distributed in the Ivory Coast…

Teva Receives FDA Warning Letter on Hungary Site
By

By
Teva Pharmaceutical Industries has received a Warning Letter on October 14, 2016, from the US Food and Drug Administration (FDA) regarding a cGMP inspection of the company’s Godollo, Budapest, Hungary…

Allergan Completes Vitae Tender Offer
By

By
Allergan has completed its tender offer to purchase all of the outstanding shares of Vitae Pharmaceuticals, a clinical-stage biopharmceutical company. As previously announced, Allergan offered to purchase all outstanding shares of…

Lilly, Merck & Co., Pfizer, and Roche Lead New Drug Approvals
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Lilly, Merck, Pfizer, and Roche. Editor’s Note: This article is updated on a continuous basis for…

Allergan, BMS, and Teva Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring news from Allergan, Bristol-Myers Squibb, GlaxoSmithKline, and Teva. Editor’s Note: This…

UNICEF, Gavi in Vaccine Supply Pact
By

By
UNICEF has entered into a supply pact with Gavi, a global vaccine alliance, to buy 450 million doses of pentavalent vaccine in the next three years at a new average…

Bill & Melinda Gates Foundation Awards Pfizer Vaccine Grant
By

By
Pfizer has been awarded a grant from the Bill & Melinda Gates Foundation to conduct a Phase I/II clinical trial of Pfizer’s vaccine candidate against group B Streptococcus (group B…

Astellas Ends Business Transfer Talks with Kaketsuken
By

By
Astellas Pharma has terminated its discussions with the Chemo-Sero-Therapeutic Research Institute (Kaketsuken), a Kumamoto,Japan-based organization that researches, develops, manufactures, and supplies vaccines and blood plasma products, with respect to the potential…